全部

 +
Citation
165 条搜索结果 for CD3
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation
Authors: Shujuan Zhou, Fanyan Meng, Shiyao Du, Hanqing Qian, Naiqing Ding, Huizi Sha, Mei Zhu, Xiaoxiao Yu, Lifeng Wang, Baorui Liu, Jia Wei
Journal: J Immunother Cancer
PubMed ID: 33986122
Doi: 10.1136/jitc-2020-001925
Products & Services: Gene Synthesis   
PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment
Authors: Tomohiro Takehara, Ei Wakamatsu, Hiroaki Machiyama, Wataru Nishi, Katsura Emoto, Miyuki Azuma, Kenzo Soejima, Koichi Fukunaga, Tadashi Yokosuka
Journal: Commun Biol
PubMed ID: 33990697
Doi: 10.1038/s42003-021-02111-3
Products & Services: Catalog Peptides   
CAR and TRuC redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII
Authors: Jyoti Rana , Daniel J Perry, Sandeep Rp Kumar, Maite Muñoz-Melero, Rania Saboungi, Todd M Brusko, Moanaro Biswas
Journal: Mol Ther
Doi: ymthe.2021.04.034
Products & Services: Gene Synthesis   
Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect
Authors: Liping Zhong, Wei Shi, Lu Gan, Xiuli Liu, Yu Huo, Pan Wu, Zhikun Zhang, Tao Wu, Hongmei Peng, Yong Huang, Yongxiang Zhao, Yulin Yuan, Zhiming Deng, Hongliang Tang
Journal: Theranostics
PubMed ID: 33995664
Doi: 10.7150/thno.53121
Products & Services: Bacterial Expression   
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells
Authors: David J DiLillo, Kara Olson, Katja Mohrs, Thomas Craig Meagher, Kevin Bray, Olga Sineshchekova, Thomas Startz, Jessica Kuhnert, Marc W Retter, Stephen Godin, Prachi Sharma, Frank Delfino, John Lin, Eric Smith, Gavin Thurston, Jessica R Kirshner
Journal: Blood Adv
PubMed ID: 33651100
Doi: 10.1182/bloodadvances.2020002736
Products & Services: Custom Vector Construction   
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy
Authors: Hena Khalique, Richard Baugh, Arthur Dyer, Eleanor M Scott, Sally Frost, Sarah Larkin, Janet Lei-Rossmann, Leonard W Seymour
Journal: J Immunother Cancer
PubMed ID: 33820820
Doi: 10.1136/jitc-2020-001292
Products & Services: Gene Synthesis   
Potentiating the Antitumor Activity of Cytotoxic T Cells the Transmembrane Domain of IGSF4 That Increases TCR Avidity
Authors: Hye-Ran Kim, Jeong-Su Park, Yasmin Fatima, Maiza Kausar, Jin-Hwa Park, Chang-Duk Jun
Journal: Front Immunol
PubMed ID: 33597944
Doi: 10.3389/fimmu.2020.591054
Products & Services: Peptide Synthesis   
Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting
Authors: Kang Yi Lee, Hiu Yi Wong, Qun Zeng, Jia Le Lin, Man Si Cheng, Chik Hong Kuick, Kenneth Tou En Chang, Amos Hong Pheng Loh, Herbert Schwarz
Journal: Oncoimmunology
PubMed ID: 33643694
Doi: 10.1080/2162402X.2021.1877459
Products & Services: Catalog Antibodies   
A Novel Mouse Model of Autoimmune Thyroiditis Induced by Immunization with Adenovirus Containing Full-Length Thyroglobulin cDNA: Implications to Genetic Studies of Thyroid Autoimmunity
Authors: Faustino LC, Li CW, Stefan-Lifshitz M, Kim K, Clarke OB, Tomer Y
Journal: Thyroid : official journal of the American Thyroid Association
PubMed ID: 32228171
Doi: 10.1089/thy.2019.0711
Products & Services: Gene Synthesis   
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Authors: Le Qin, Ruocong Zhao, Dongmei Chen, Xinru Wei, Qiting Wu, Youguo Long, Zhiwu Jiang, Yangqiu Li, Haipeng Wu, Xuchao Zhang, Yilong Wu, Shuzhong Cui, Wei Wei, Huihui Yao, Zixia Liu, Su Cao, Yao Yao, Zhenfeng Zhang, Peng Li
Journal: Biomark Res
PubMed ID: 32514352
Doi: 10.1186/s40364-020-00198-0
Products & Services: Custom Vector Construction